IL1B and Sepsis: Once recombinant tumour necrosis factor (TNF) and interleukin-1 (IL-1) became available in the late 1980s, and assays based on them replaced earlier methods, the concept spread to other pro-inflammatory cytokines, and from malaria and sepsis to viral and certain autoimmune diseases.